Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
New Biologic Tulisokibart Beats Placebo in UC Trial
The experimental monoclonal antibody tulisokibart safely induced clinical remission in a phase 2 randomized trial of moderately to severely active ulcerative colitis (UC). In one cohort of 135 patients, the primary endpoint of clinical remission occurred in 26% of those…
English